ANI PHARMACEUTICALS INC (ANIP)

US00182C1036 - Common Stock

69.13  -0.56 (-0.8%)

After market: 69.13 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to ANIP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 81.35. This target is 17.67% above the current price.
ANIP was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ANIP.
In the previous month the buy percentage consensus was at a similar level.
ANIP was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 69.1377.7781.0981.3587.15 - 12.50% 17.30% 17.67% 26.07%
Up and Down Grades
Date Firm Action Rating
2024-03-15 Capital One Initiate Overweight
2024-03-05 Guggenheim Maintains Buy -> Buy
2024-03-04 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-01 Truist Securities Maintains Buy -> Buy
2024-02-16 Truist Securities Maintains Buy -> Buy
2023-10-19 Guggenheim Reiterate Buy -> Buy
2023-09-13 Guggenheim Reiterate Buy -> Buy
2023-08-22 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-21 Truist Securities Reiterate Buy -> Buy
2023-08-10 Guggenheim Maintains Buy -> Buy
2023-07-27 Guggenheim Maintains Buy -> Buy
2023-07-21 Truist Securities Maintains Buy -> Buy
2023-05-09 Guggenheim Maintains Buy
2023-05-09 Raymond James Maintains Outperform
2023-05-09 Truist Securities Maintains Buy
2023-05-09 HC Wainwright & Co. Maintains Buy
2023-03-13 HC Wainwright & Co. Maintains Buy
2023-03-01 Guggenheim Initiate Buy
2023-02-21 HC Wainwright & Co. Reiterate Buy
2022-09-07 HC Wainwright & Co. Initiate Buy
2022-08-09 Raymond James Maintains Outperform
2021-11-02 Raymond James Maintains Outperform
2021-11-02 Truist Securities Initiate Buy
2021-05-10 Raymond James Maintains Outperform